GDF15 and intermediate coronary syndrome: GDF-15 is emerging as a prognostic factor in ACS patients and is associated with NSTEMI, unstable angina pectoris, and STEMI, which are the causes of the erosion or rupture of vulnerable atherosclerotic plaques resulting in AMI or death (29–31).